Predilife S.A.
Paris Stock Exchange ALPRE.PA
Predilife S.A. Total Assets for the year ending December 31, 2023: USD 9.73 M
Predilife S.A. Total Assets is USD 9.73 M for the year ending December 31, 2023, a 91.65% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Predilife S.A. Total Assets for the year ending December 31, 2022 was USD 5.08 M, a 12.52% change year over year.
-
Predilife S.A. Total Assets for the year ending December 31, 2021 was USD 4.51 M, a -9.80% change year over year.
-
Predilife S.A. Total Assets for the year ending December 31, 2020 was USD 5.00 M, a 230.38% change year over year.
-
Predilife S.A. Total Assets for the year ending December 31, 2019 was USD 1.51 M.
Key data
| Date | Total Assets | Current Liabilities | Total Non-Current Liabilities | Shareholders' Equity |
|---|
Market news
Loading...
Paris Stock Exchange: ALPRE.PA
| CEO | Mr. Stephane Ragusa |
| IPO Date | Dec. 21, 2018 |
| Location | France |
| Headquarters | 39, Rue Camille Desmoulins |
| Employees | 18 |
| Sector | Health Care |
| Industries | |
Description
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
Key trends
Past 5 years
Similar companies
Lexibook - Linguistic Electronic System Société anonyme
USD 4.32
0.60%
MedinCell S.A.
USD 16.86
0.98%
StockViz Staff
January 15, 2025
Any question? Send us an email